Reply
Xiao‐Xia Niu, Ya Deng, Chun‐Yan Wang, Dong Ji – 2 February 2022
Reply
Jonathan G. Stine, Ian R. Schreibman, Alison J. Faust, Jessica Dahmus, Benjamin Stern, Christopher Soriano, Gloriany Rivas, Breianna Hummer, Scot R. Kimball, Nathaniel R. Geyer, Vernon M. Chinchilli, Kathryn Schmitz, Christopher Sciamanna – 2 February 2022
Intermittent Fasting as a Treatment for Nonalcoholic Fatty Liver Disease: What Is the Evidence?
Zoe N. Memel, Jeffrey Wang, Kathleen E. Corey – 2 February 2022
Sofosbuvir‐velpatasvir‐voxilaprevir in adolescents 12 to 17 years old with HCV infection
Guiseppe Indolfi, Deirdre Kelly, Gabriella Nebbia, Raffaele Iorio, Anna Mania, Vania Giacomet, Leszek Szenborn, Jiang Shao, Mun Sang Yue, Chia‐Hsiang Hsueh, Bandita Parhy, Kathryn Kersey, Alessandra Mangia, Malgorzata Pawlowska, Sanjay Bansal – 2 February 2022
Intermittent Fasting as a Treatment for Nonalcoholic Fatty Liver Disease: What Is the Evidence?
Zoe N. Memel, Jeffrey Wang, Kathleen E. Corey – 2 February 2022
p21‐activated kinase 4 inhibition protects against liver ischemia/reperfusion injury: Role of nuclear factor erythroid 2‐related factor 2 phosphorylation
Yuancheng Mao, Chang Yeob Han, Lihua Hao, Younho Lee, Jung Beom Son, Hwangeun Choi, Mi Rin Lee, Jae Do Yang, Suk Kyun Hong, Kyung‐Suk Suh, Hee Chul Yu, Nam Doo Kim, Eun Ju Bae, Byung‐Hyun Park – 1 February 2022
Letter to the editor: Is transjugular intrahepatic portosystemic shunt the best treatment for adults without cirrhosis with extrahepatic portal vein obstruction and portal hypertension?
Caroline P. Lemoine, Riccardo Superina – 1 February 2022
KIAA1199 drives immune suppression to promote colorectal cancer liver metastasis by modulating neutrophil infiltration
Haihong Wang, Biying Zhang, Ruiqi Li, Jiayuan Chen, Guojie Xu, Ying Zhu, Jiao Li, Qing Liang, Qingling Hua, Lanqing Wang, Lu Wen, Min Jin, Jun Fan, Dejun Zhang, Lei Zhao, Dandan Yu, Zhenyu Lin, Jinghua Ren, Tao Zhang – 1 February 2022
When the Sun Sets, Who Doth Not Look for Night?
Randi J. Ryan, Timucin Taner, Julie K. Heimbach – 1 February 2022
Viral integrations in chronic hepatitis B infection: Purposeless passenger or problematic promoter of persistence?
Thomas Tu, Henrik Zhang – 1 February 2022